FDA approval for new Cochlear sound processor

Cochlear, a global leader in implantable hearing solutions, has received US FDA clearance and CE Mark accreditation for the Baha 6 Max Sound Processor.

The company said the new processor is designed to improve hearing outcomes for people with single‐sided deafness, conductive or mixed hearing loss.

It said with a fitting range of up to 55 dB SNHL (sensorineural hearing level) in the same small size as current 45 dB devices1, the Baha 6 Max is the first of its kind – “a premium‐power bone conduction sound processor designed for powerful hearing performance.”

The Baha 6 Max is also the first bone conduction sound processor to offer direct streaming from Apple and Android devices. Direct streaming from Apple devices has been available in the Baha 5 Sound Processor since 2015.

“The new processor provides additional power in the smallest form and is designed to provide the clearest, richest and most natural sound possible, reducing the need to choose between hearing performance and size.

“The Baha 6 Max Sound Processor will be launched across the US and Europe over the coming months,” added the company.

/Public Release. This material comes from the originating organization and may be of a point-in-time nature, edited for clarity, style and length. View in full here.